November 8, 2026
Business

Piramal Pharma points to early recovery signs after seeing red in Q3(Soban News)

The company posted its results for the third quarter of FY26 late on Wednesday evening, with its revenue dipping 3% year-on-year to ₹2,140 crore, and slipping to a loss of ₹136 crore from a net profit of ₹4 crore in Q3FY25. Its ebitda margin shrank from 16% in Q3FY25 to 11% this fiscal.

​The company posted its results for the third quarter of FY26 late on Wednesday evening, with its revenue dipping 3% year-on-year to ₹2,140 crore, and slipping to a loss of ₹136 crore from a net profit of ₹4 crore in Q3FY25. Its ebitda margin shrank from 16% in Q3FY25 to 11% this fiscal. by Soban News (international And National News)

Related posts

US consumers back in focus as retailers get earnings ready

News-Soban-Admin

3,800 workers are set to strike Monday at one of the nations largest meatpacking plants(Soban News)

News-Soban-Admin

Former Test cricketer punished after retirement with 2-year ban; he had used ‘cocaine’ during a game | Cricket – Hindustan Times(Soban News)

News-Soban-Admin

Leave a Comment